Newsroom
Newsroom
Industry News
The company was awarded for its ability to outperform conventional manufacturing methods for critical pharmaceutical ingredients and rapidly reach a commercial scale in the U.S....
Press Releases
Company awarded for its ability to outperform conventional manufacturing methods for critical pharmaceutical ingredients and rapidly reach commercial scale in the U.S....
Industry News
Antheia, which is using fermentation to manufacture drug ingredients that are normally produced agriculturally, announced its first commercial delivery this week....
Industry News
Antheia, a pharmaceutical ingredient manufacturer, has delivered its first commercial order of thebaine to a leading pharmaceutical customer....
Industry News
This first commercial-scale thebaine delivery redefines essential medicine supply chains, supporting biomanufacturing’s future in pharma....
Industry News
The company was awarded for its ability to outperform conventional manufacturing methods for critical pharmaceutical ingredients and rapidly reach a commercial scale in the U.S....
Press Releases
Company awarded for its ability to outperform conventional manufacturing methods for critical pharmaceutical ingredients and rapidly reach commercial scale in the U.S....
Industry News
Antheia, which is using fermentation to manufacture drug ingredients that are normally produced agriculturally, announced its first commercial delivery this week....
Industry News
Antheia, a pharmaceutical ingredient manufacturer, has delivered its first commercial order of thebaine to a leading pharmaceutical customer....
Industry News
This first commercial-scale thebaine delivery redefines essential medicine supply chains, supporting biomanufacturing’s future in pharma....
Industry News
Antheia announced that it has received $17 million in funding to be used for projects focused on building domestic pharmaceutical production sites....
Industry News
The company secured funding through government project agreement with the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), alongside strategic investment from In-Q-Tel and Echo...
Industry News
Antony Blinken tours Antheia biotech lab, emphasizing its potential to address nationwide medicine shortages by overcoming supply chain issues with advanced bio-technology...
Industry News
In this interview with Antheia and Olon, two leading companies in the life sciences industry, we discussed their ongoing partnership, market trends, and the future...
Industry News
Antheia and Olon have announced a continuation of partnership, leveraging Olon’s fermentation infrastructure for the manufacture of Antheia’s early products...
Industry News
Antheia is a synthetic biology company in the business of genetically engineering microorganisms to produce commercial products....
Blog Posts
Since launching Antheia in 2015, we’ve made tremendous strides toward our mission to transform pharmaceutical supply chains for essential medicines. We’ve strengthened our leadership team...
Blog Posts
Antheia was founded in 2015 by Dr. Christina Smolke, CEO and Dr. Kristy Hawkins, CSO and is based in Menlo Park, California. Antheia’s co-founders are...
Blog Posts
Each year, SynBioBeta hosts the The Global Synthetic Biology Conference to showcase the latest cutting-edge developments in biology that are changing how we solve global...
Blog Posts
We continue to see the U.S. government setting policy priorities that underscore the importance of both building a robust American bioeconomy and strengthening domestic pharmaceutical...
Blog Posts
Synthetic chemistry is an essential part of drug development, opening the door for scientists to create complex small molecules with specific properties. Small molecule drugs...
Blog Posts
We’ve recently welcomed Jesse Ahrendt, our new Senior Vice President of Quality Assurance and Regulatory Affairs, who will lead our quality and regulatory efforts. He...